Provided by Tiger Fintech (Singapore) Pte. Ltd.

DaVita HealthCare Partners

141.16
-2.2200-1.55%
Volume:708.80K
Turnover:100.64M
Market Cap:10.66B
PE:13.96
High:144.07
Open:143.82
Low:140.81
Close:143.38
Loading ...

GEHC Stock May Gain on FDA's Nod for the Updated Voluson Expert Series

Zacks
·
04 Feb

For Improving Transplant Access, Collaboration Holds the Key

ACCESS Newswire
·
03 Feb

Two Of 2024's Best Stocks Rule The Market Yet Again This Year

Blockhead
·
03 Feb

DaVita (NYSE:DVA) jumps 3.5% this week, though earnings growth is still tracking behind five-year shareholder returns

Simply Wall St.
·
01 Feb

Surmodics Stock Down Despite Q1 Earnings Beat, Gross Margin Up

Zacks
·
01 Feb

ANGO Stock Looks Promising on New Ischemia Study for Auryon System

Zacks
·
31 Jan

Heroes in Scrubs: Celebrating the Importance of Nurses in Kidney Care

ACCESS Newswire
·
31 Jan

4 Stocks Trading Near 52-Week High With Room to Rise Further

Zacks
·
31 Jan

Is DaVita Inc. (DVA) Among Warren Buffett’s Longest-Held Stocks?

Insider Monkey
·
31 Jan

DaVita Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
31 Jan

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

PR Newswire
·
31 Jan

CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised

Zacks
·
31 Jan

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now

Zacks
·
30 Jan

DaVita Inc. (DVA): Enhancing Kidney Care Through Advanced AI Models

Insider Monkey
·
30 Jan

DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note

Zacks
·
30 Jan

DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's Why

Zacks
·
30 Jan

Stryker Stock Falls on Deal to Sell Its U.S. Spinal Implants Business

Zacks
·
30 Jan

Is CareDx (CDNA) Outperforming Other Medical Stocks This Year?

Zacks
·
29 Jan

DaVita Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
29 Jan

Bernstein Adjusts Price Target on DaVita to $184 From $161, Maintains Market Perform Rating

MT Newswires Live
·
29 Jan